Results 11 to 20 of about 27,806 (222)

Focal Segmental Glomerulosclerosis [PDF]

open access: yesClinical Journal of the American Society of Nephrology, 2017
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant–important disease characteristics.
Avi Z, Rosenberg, Jeffrey B, Kopp
openaire   +2 more sources

Adult-Onset Genetic Focal Segmental Glomerulosclerosis: A Tale of Two Mutations

open access: yesRevista Portuguesa de Nefrologia e Hipertensão, 2023
Focal segmental glomerulosclerosis (FSGS) is a kidney histologic lesion that may be caused by multiple aetiologies and pathophysiological mechanisms, with podocyte injury and depletion as the common denominator.
Luís Leite de Sousa   +4 more
doaj   +1 more source

Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association

open access: yesFrontiers in Medicine, 2020
Focal segmental glomerulosclerosis (FSGS) is a histological term that describes a pathologic renal entity affecting both adults and children, with a wide array of possible underlying etiologies.
Manuel Alfredo Podestà   +1 more
doaj   +1 more source

Unwinding focal segmental glomerulosclerosis [PDF]

open access: yesF1000Research, 2017
Focal segmental glomerulosclerosis (FSGS) represents the most common primary glomerular disease responsible for the development of end-stage renal disease (ESRD) in the United States (US). The disease progresses from podocyte injury to chronic kidney disease (CKD), ultimately leading to total nephron degeneration.
Vasil Peev, Eunsil Hahm, Jochen Reiser
openaire   +2 more sources

Loss of phosphatidylserine flippase β-subunit Tmem30a in podocytes leads to albuminuria and glomerulosclerosis

open access: yesDisease Models & Mechanisms, 2021
The asymmetric distribution of phosphatidylserine (PS) in the cytoplasmic leaflet of eukaryotic cell plasma membranes is regulated by a group of P4-ATPases (named PS flippases) and the β-subunit TMEM30A.
Wenjing Liu   +9 more
doaj   +1 more source

Pilot trial of fk 506 in the management of steroid-resistant nephrotic syndrome [PDF]

open access: yes, 1993
Seven patients with steroid-resistant nephrotic syndrome were treated with FK 506 monotherapy. Four patients were children with focal sclerosing glomerulonephritis (FSGS).
Ellis, D   +9 more
core   +1 more source

Focal segmental glomerulosclerosis in which urinary protein improved after surgical treatment for acromegaly: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Focal segmental glomerulosclerosis is characterized by partial (segmental) sclerotic lesions in some glomeruli (focal). Primary focal segmental glomerulosclerosis is generally considered resistant to steroid therapy.
Arina Yamasaki   +9 more
doaj   +1 more source

A Case of Focal Segmental Glomerulosclerosis in Turner Syndrome [PDF]

open access: yesKosin Medical Journal, 2015
Turner syndrome is usually accompanied with various anomalies. Congenital urological and renal abnormalities are often associated with this syndrome. The occurrence of glomerulonephritis is uncommon.
A Rum Han   +5 more
doaj   +1 more source

Eluate derived by extracorporal antibody-based immunoadsorption elevates the cytosolic Ca2+ concentration in podocytes via B-2 kinin receptors [PDF]

open access: yes, 2002
Background/Aim: Patients with idiopathic focal segmental glomerulosclerosis (FSGS) often develop a recurrence of the disease after kidney transplantation.
Fink, E.   +6 more
core   +1 more source

A case report: Familial glucocorticoid deficiency associated with familial focal segmental glomerulosclerosis

open access: yesBMC Endocrine Disorders, 2012
Background Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by isolated glucocorticoid deficiency in the presence of normal plasma renin and aldosterone level.
Ram Nanik, Asghar Ali, Islam Najmul
doaj   +1 more source

Home - About - Disclaimer - Privacy